Conduent Launches GenAI Solution for Reportable Event Detection
Conduent Incorporated (Nasdaq: CNDT), a global provider of technology-driven business solutions, announced the rollout of an innovative GenAI-based platform designed to transform how reportable events are identified and managed within the pharmaceutical and life sciences sectors.
Revolutionizing Pharmaceutical Compliance
The new system, developed in partnership with Microsoft Azure OpenAI, automates detection and classification of reportable events across multiple customer interaction channels. This innovation aims to enhance accuracy, reduce reporting delays, and meet FDA compliance standards more efficiently.
"By integrating advanced Generative AI with regulatory workflows, we’re helping companies achieve faster and more reliable compliance outcomes," said a Conduent spokesperson.
Contact Information
- Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
Author Summary
Conduent’s new GenAI-based compliance platform automates event detection in pharma, streamlining regulatory accuracy and accelerating FDA reporting processes.